Items where authors include "Peters, S."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Peters, S., Letovanec, I., Mauer, M. et al. (15 more authors) (2023) Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. Lung Cancer, 175. pp. 141-151. ISSN 0169-5002

Roodbari, H., Nielsen, K. orcid.org/0000-0001-9685-9570, Axtell, C. et al. (2 more authors) (2022) Testing middle range theories in realist evaluation : a case of a participatory organisational intervention. International Journal of Workplace Health Management, 15 (6). pp. 694-710. ISSN 1753-836X

Wysocki, O. orcid.org/0000-0002-7053-4919, Zhou, C. orcid.org/0000-0002-6938-4685, Rogado, J. orcid.org/0000-0002-9795-8762 et al. (71 more authors) (2022) An international comparison of presentation, outcomes and CORONET predictive score performance in patients with cancer presenting with COVID-19 across different pandemic waves. Cancers, 14 (16). 3931. ISSN 2072-6694

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Ejedepang, D. et al. (19 more authors) (2021) Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung Cancer, 161. pp. 76-85. ISSN 0169-5002

Roodbari, H., Nielsen, K. orcid.org/0000-0001-9685-9570, Axtell, C. orcid.org/0000-0002-4125-6534 et al. (2 more authors) (2021) Developing initial middle range theories in realist evaluation : a case of an organisational intervention. International Journal of Environmental Research and Public Health, 18 (16). 8360.

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Hasan, B. et al. (35 more authors) (2020) A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial. Journal of Thoracic Oncology, 15 (10). pp. 1647-1656. ISSN 1556-0864

Ürün, Y., Hussain, S.A. orcid.org/0000-0003-1552-511X, Bakouny, Z. et al. (13 more authors) (2020) Survey of the impact of COVID-19 on oncologists’ decision making in cancer. Jco Global Oncology, 6. pp. 1248-1257. ISSN 2687-8941

Peters, S., Clézardin, P., Márquez-Rodas, I. et al. (2 more authors) (2019) The RANK–RANKL axis : an opportunity for drug repurposing in cancer? Clinical and Translational Oncology, 21 (8). pp. 977-991. ISSN 1699-048X

Sorensen, G., Peters, S., Nielsen, K. orcid.org/0000-0001-9685-9570 et al. (6 more authors) (2019) Improving Working Conditions to Promote Worker Safety, Health and Wellbeing for Low-Wage Workers: The Workplace Organizational Health Study. International Journal of Environmental Research and Public Health, 16 (8). 1449. ISSN 1661-7827

Chaudhuri, R., Allen, A., Owen, P. et al. (11 more authors) (2009) Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics, 10 (1). p. 291. ISSN 1471-2164

Wearden, A. J., Riste, L., Dowrick, C. et al. (8 more authors) (2006) Fatigue Intervention by Nurses Evaluation - The FINE Trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome: study protocol. [ISRCTN74156610]. BMC Medicine. 9. -. ISSN 1741-7015